評註
最新研究發現甲狀腺癌患者本來就是容易罹患其他原發惡性腫瘤 (primary malignancy), 常見的是乳癌; 研究更發現接受放射碘治療的甲狀腺癌病友得到其他癌症的機會是下降的, 而且累積治療劑量高於100毫居里的罹患其他癌症的機會也比較低
原文請參考: Incidence of Non-thyroidal Primary Malignancy and the Association with I-131 Treatment in Patients with Differentiated Thyroid Cancer.
NTPMs are not uncommon in patients with DTC and usually antecede the DTC. In a population of mostly low risk DTC patients, in whom limited dose activities of RAI are usually administered, this treatment is apparently not associated with an overall increased risk of SPMs relative to no RAI treatment.
請先 登入 以發表留言。